| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 107 |
| 1 | TACROLIMUS | 97 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 95 |
| 3 | TACROLIMUS OINTMENT 0.1% | 95 |
| 4 | MYCOPHENOLATE MOFETIL | 69 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 69 |
| 6 | VALGANCICLOVIR | 49 |
| 7 | VALGANCICLOVIR HYDROCHLORIDE | 49 |
| 8 | VALGANCICLOVIR HYDROCHLORIDE POWDER, | 43 |
| 9 | CYCLOSPORINE | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 2 | 0.0041 |
| 1 | VALGANCICLOVIR | 49 | 0.0026 |
| 2 | BASILIXIMAB | 22 | 0.0018 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 15 | 0.0018 |
| 4 | SIROLIMUS | 19 | 0.0014 |
| 5 | MYCOPHENILIC ACID | 24 | 0.0011 |
| 6 | OMEPRAZOLE 20MG | 1 | 0.0009 |
| 7 | MYCOPHENOLIC ACID | 28 | 0.0009 |
| 8 | AMPICILLIN INJECTION | 6 | 0.0008 |
| 9 | TACROLIMUS OINTMENT 0.1% | 95 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 50 | 0.0022 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 24 | 0.0011 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 3 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 4 | Polyene Antifungal [EPC] | 10 | 0.0002 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 30 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 15 | 0.0002 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 10 | 0.0002 |
| 8 | Tetracycline-class Drug [EPC] | 13 | 0.0002 |
| 9 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |